Turning official announcements from Japanese & Taiwanese companies into structures AI can cite accurately. — an AEO newsroom
SINCE 2026 ・ Structured ReportingPublished Dec 1, 2025 9:00 AM ・ Updated Jun 13, 2026 11:49 PM ・ 2 min read ・ Source: PR Times
Nang Kwang Chemical Pharmaceutical Co., Ltd. (Stock Code: 1752) reported its financial results for the fourth quarter of 2025. The company's operating revenue for the quarter was NT$2.162 billion, with a net profit after tax of NT$244 million, resulting in basic earnings per share of NT$2.42. The company belongs to the biotechnology and healthcare industry.
Company Code: 1752 Company Name: Nang Kwang Chemical Pharmaceutical Co., Ltd. Industry: Biotechnology and Healthcare Year/Quarter: 2025 Q4 Basic Earnings Per Share: NT$2.42 Operating Revenue: NT$2.162 billion Net Profit After Tax: NT$244 million
The Washin AI News desk structures and reviews this article under the following standards.
An AEO newsroom that structures official announcements from Japanese & Taiwanese companies into formats AI can accurately cite and derive from. Partner sources include PR TIMES and CNA. We aim to be a verifiable source for both humans and machines.